Selected polymorphisms of GSTP1 and TERT were associated with glioma risk in Han Chinese

Cancer Epidemiology

Volumn 36, Issue 6, 2012, Pages 525-527

  Li, Gang ^a   Jin, Tian Bo ^b   Wei, Xiao Bin ^c   He, Shi Ming ^a   Liang, Hong Juan ^a   Yang, Hai Xia ^a   Cui, Yan ^b   Chen, Chao ^b   Cai, Lin Bo ^d   Gao, Guo Dong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NORTHWEST UNIVERSITY   (China)

^c HANZHONG CENTRAL HOSPITAL   (China)

^d Guangdong 999 Brain Hospital   (China)

Author keywords

Case control study; Glioma; GSTP1; Tagging single nucleotide polymorphism (tSNP); TERT

Indexed keywords

GLUTATHIONE TRANSFERASE P1; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; AGED; ARTICLE; CANCER RISK; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLIOMA; GLUTATHIONE S-TRANSFERASE PI; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TELOMERASE;

EID: 84868301430     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2012.06.008     Document Type: Article

References (19)

1. Bondy M.L., Scheurer M.E., Malmer B., Barnholtz-Sloan J.S., Davis F.G., ll'yasova D., et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 2008, 113:1953-1968.
2. Wrensch M., Jenkins R.B., Chang J.S., Yeh R.F., Xiao Y., Decker P.A., et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nature Genetics 2009, 41:905-908.
3. Liu Y., Shete S., Hosking F., Robertson L., Houlston R., Bondy M. Genetic advances in glioma: susceptibility genes and networks. Current Opinion in Genetics and Development 2010, 20:239-244.
4. Shete S., Hosking F.J., Robertson L.B., Dobbins S.E., Sanson M., Malmer B., et al. Genome-wide association study identifies five susceptibility loci for glioma. Nature Genetics 2009, 41:899-904.
5. Bethke L., Webb E., Murray A., Schoemaker M., Johansen C., Christensen H.C., et al. Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Human Molecular Genetics 2008, 17:800-805.
6. Andersson U., Schwartzbaum J., Wiklund F., Sjöström S., Liu Y., Tsavachidis S., et al. A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. Acta Oncologica 2010, 49:767-775.
7. Lai R., Crevier L., Thabane L. Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis. Cancer Epidemiology, Biomarkers and Prevention 2005, 14:1784-1790.
8. Brenner A.V., Butler M.A., Wang S.S., Ruder A.M., Rothman N., Schulte P.A., et al. Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis 2007, 28:2543-2547.
9. Rajaraman P., Wang S.S., Rothman N., Brown M.M., Black P.M., Fine H.A., et al. Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiology, Biomarkers and Prevention 2007, 16:1655-1661.
10. Wrensch M., Kelsey K.T., Liu M., Miike R., Moghadassi M., Aldape K., et al. Glutathione-S-transferase variants and adult glioma. Cancer Epidemiology, Biomarkers and Prevention 2004, 13:461-467.
11. Li S.Q., Jin T.B., Zhang J.Y., Lou H.L., Yang B., Li Y., et al. Polymorphisms of TREH IL4R and CCDC26 genes associated with risk of glioma. Cancer Epidemiology 2012, 36:283-287.
12. Gabriel S., Ziaugra L., Tabbaa D. SNP genotyping using the Sequenom MassARRAY iPLEX platform. Current Protocols in Human Genetics 2009, Chapter 2, Unit 2 12.
13. Thomas R.K., Baker A.C., Debiasi R.M., Winckler W., Laframboise T., Lin W.M., et al. High-throughput oncogene mutation profiling in human cancer. Nature Genetics 2007, 39:347-351.
14. Adamec C. Example of the use of the nonparametric test. Test X2 for comparison of 2 independent examples. Ceskoslovenske Zdravotnictvi 1964, 12:613-619.
15. Bland J.M., Altman D.G. Statistics notes. The odds ratio. British Medical Journal 2000, 320:1468.
16. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics 2007, 81:559-575.
17. Ali-Osman F., Akande O., Antoun G., Mao J.X., Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. Journal of Biological Chemistry 1997, 272:10004-10012.
18. Pinarbasi H., Silig Y., Gurelik M. Genetic polymorphisms of GSTs and their association with primary brain tumor incidence. Cancer Genetics and Cytogenetics 2005, 156:144-149.
19. Rafnar T., Sulem P., Stacey S.N., Geller F., Gudmundsson J., Sigurdsson A., et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nature Genetics 2009, 41:217-221.